Worst Pills
levalbuterol (XOPENEX, XOPENEX HFA)

Worst Pills, Best Pills Newsletter Articles

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a primary subject of discussion
  • Update on the Long-Term Treatment Of Chronic Obstructive Pulmonary Disease [hide all summaries]
    (November 2015)
    In this article, we provide a detailed update of the various drugs available for the long-term management of chronic obstructive pulmonary disease (COPD). Learn which drugs are safest for treating COPD and which ones we have designated as Do Not Use.
  • Update: Treatment of Chronic Asthma [hide all summaries]
    (August 2015)
    Asthma is a common disease afflicting more than 16 million American adults and 6 million children. Find out the safest and most effective options for managing this chronic lung disease.
  • Treatment for Chronic Obstructive Pulmonary Disease [hide all summaries]
    (February 2013)
    Commonly known as emphysema, chronic obstructive pulmonary disease (COPD) affects an estimated 24 million Americans, only half of whom are diagnosed. This article presents recent information regarding the use of drug treatments, including inhaled anti-inflammatory steroids, as well as important nondrug treatments that can be used as an adjunct to drug therapy.
  • Smoke & Mirror Marketing (& Other Clever Big Pharma Tricks) [hide all summaries]
    (May 2010)
    The article reviews 12 prescription drugs, many of which are top-sellers, all of which are greatly overpriced in comparison to older "versions" of the same drugs. The patents on the old drugs expired so the "innovative" companies patented these new products, gaining a patent on them, and, for all practical purposes, using them as a license to print money. There is no evidence that any of the new ones are better than the now less-expensive, old versions.
  • A Review of Levalbuterol (XOPENEX HFA) Inhaler for Asthma [hide all summaries]
    (February 2007)
    If you are presently using albuterol and your asthma is adequately controlled, there is no medical reason why you should be switched to levalbuterol. There is no convincing evidence that it is any safer or more effective than the older, much less expensive short-acting beta agonist, albuterol.
  • Selling New Drugs Using Smoke and Mirror (Images) [hide all summaries]
    (March 2003)
    You should avoid these "new" single mirror images of old drugs, not out of concern about their safety or effectiveness, but because they are the same as the old drugs. In the long run, they cause economic harm both to individuals and to the health care system because they have come on the market with extended monopoly protection. Article lists some examples.

SHOW secondary search results for levalbuterol (XOPENEX, XOPENEX HFA)

Copyright © 2017 Public Citizen's Health Research Group. All rights reserved. https://www.worstpills.org/